TEVA PHARMACEUTICAL INDUSTRIES LTD·4

Mar 7, 4:25 PM ET

Fox Christine 4

4 · TEVA PHARMACEUTICAL INDUSTRIES LTD · Filed Mar 7, 2025

Insider Transaction Report

Form 4
Period: 2025-03-05
Fox Christine
EVP, U.S. Commercial
Transactions
  • Award

    Restricted Share Units

    2025-03-05+71,27871,278 total
    Ordinary Shares (71,278 underlying)
Footnotes (3)
  • [F1]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
  • [F2]Restricted share units were granted on March 5, 2025, with 17,819 vesting on each of March 5, 2026, March 5, 2027 and March 5, 2028, and 17,821 vesting on March 5, 2029.
  • [F3]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4